# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TELA Bio (NASDAQ:TELA) affirms FY2025 sales outlook from $85.000 million-$88.000 million to $85.000 million-$88.000 million vs ...
TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.18) by...